Regression of Cervical Intraepithelial Neoplasia (CIN) 1 or HPV infection after treatment with cervix coagulation

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20170207002

Enrollment

Registered

2017-02-07

Start date

2016-12-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

regression rate&#44

Interventions

cervix coagulation ,observation as standard guideline

Experimental Procedure/Surgery,No Intervention No treatment

cervix coagulation,observe

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Pathological reported CIN 1 or low grade squamous intraepithelial lesion (LSIL) or HPV infection of cervix 2. age 18 years old or above 3. Understand in Thai language 4. Informed consent

Exclusion criteria

Exclusion criteria: 1. cervical lesion involved more than 75% cervical surface area 2. Unsatisfactory colposcopy 3. Endocervical involvement 4. Pregnancy 5. Prior treatment of CIN

Design outcomes

Primary

Measure	Time frame
regression rate of cervical intraepithelial neoplasia 1 year 3 months regression rate	—

Secondary

Measure	Time frame
adverse event 1 year rate	—

Contacts

Public ContactJesada Wutitammasuk

Siriraj hospital

tarzantalent@hotmail.com0876357598

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026